ArticleSpringerPlus2015

Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients.

Elena Yaiza Romero-Ventosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.